$2.45T
Total marketcap
$73.55B
Total volume
BTC 50.71%     ETH 14.89%
Dominance

Sprint Bioscience AB (publ) 5JA1.F Stock

0.1 EUR {{ price }} 29.693750% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
7.64M EUR
LOW - HIGH [24H]
0.1 - 0.1 EUR
VOLUME [24H]
5.5K EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.34 EUR

Sprint Bioscience AB (publ) Price Chart

Sprint Bioscience AB (publ) 5JA1.F Financial and Trading Overview

Sprint Bioscience AB (publ) stock price 0.1 EUR
Previous Close 0.03 EUR
Open 0.03 EUR
Bid 0.03 EUR x N/A
Ask 0.06 EUR x N/A
Day's Range 0.03 - 0.03 EUR
52 Week Range 0.01 - 0.3 EUR
Volume 550 EUR
Avg. Volume 0 EUR
Market Cap 2.72M EUR
Beta (5Y Monthly) 1.354789
PE Ratio (TTM) N/A
EPS (TTM) -0.34 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

5JA1.F Valuation Measures

Enterprise Value 2.26M EUR
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Sprint Bioscience AB (publ) Stock Price History

Beta (5Y Monthly) 1.354789
52-Week Change -87.55%
S&P500 52-Week Change 20.43%
52 Week High 0.3 EUR
52 Week Low 0.01 EUR
50-Day Moving Average 0.04 EUR
200-Day Moving Average 0.06 EUR

5JA1.F Share Statistics

Avg. Volume (3 month) 0 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 69.8M
Float 53.6M
Short Ratio N/A
% Held by Insiders 35.31%
% Held by Institutions 2.58%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -74.62%
Return on Equity (ttm) -161.46%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) 1805.69%
Gross Profit (ttm) -12847000 EUR
EBITDA N/A
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) -0.12
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 1.742
Book Value Per Share (mrq) N/A

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Sprint Bioscience AB (publ)

Country Germany
State N/A
City Huddinge
Address Novum
ZIP 141 57
Phone 46 84 11 44 55
Website https://www.sprintbioscience.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 29

Sprint Bioscience AB (publ) develops pharmaceutical products in the areas of cancer and metabolism in Sweden, Europe, the United States, and Asia. It engages in developing VPS34, a drug candidate for the treatment of various types of cancer; and PETRA01, a drug candidate for the treatment of cancer. The company also focuses on research of products for the treatment of tumor metabolism and type 2 diabetes. Sprint Bioscience AB (publ) was founded in 2009 and is based in Huddinge, Sweden.

Q&A For Sprint Bioscience AB (publ) Stock

What is a current 5JA1.F stock price?

Sprint Bioscience AB (publ) 5JA1.F stock price today per share is 0.1 EUR.

How to purchase Sprint Bioscience AB (publ) stock?

You can buy 5JA1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Sprint Bioscience AB (publ)?

The stock symbol or ticker of Sprint Bioscience AB (publ) is 5JA1.F.

Which industry does the Sprint Bioscience AB (publ) company belong to?

The Sprint Bioscience AB (publ) industry is Biotechnology.

How many shares does Sprint Bioscience AB (publ) have in circulation?

The max supply of Sprint Bioscience AB (publ) shares is 78.46M.

What is Sprint Bioscience AB (publ) Price to Earnings Ratio (PE Ratio)?

Sprint Bioscience AB (publ) PE Ratio is now.

What was Sprint Bioscience AB (publ) earnings per share over the trailing 12 months (TTM)?

Sprint Bioscience AB (publ) EPS is -0.34 EUR over the trailing 12 months.

Which sector does the Sprint Bioscience AB (publ) company belong to?

The Sprint Bioscience AB (publ) sector is Healthcare.